These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1839126

  • 1. Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight.
    Dieben TO, van Beek A, Coelingh Bennink HJ.
    Arzneimittelforschung; 1991 Sep; 41(9):996-8. PubMed ID: 1839126
    [Abstract] [Full Text] [Related]

  • 2. Cycle control and side effects of a new combiphasic oral contraceptive regimen.
    Dieben TO, op ten Berg MT, Coelingh Bennink HJ.
    Arzneimittelforschung; 1994 Jul; 44(7):877-9. PubMed ID: 7945527
    [Abstract] [Full Text] [Related]

  • 3. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G.
    Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
    [Abstract] [Full Text] [Related]

  • 4. A clinical overview of a new triphasic contraceptive containing gestodene.
    Christie T.
    Int J Fertil; 1989 Sep; 34 Suppl():40-9. PubMed ID: 2576257
    [Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.
    Bilotta P, Favilli S.
    Arzneimittelforschung; 1988 Jul; 38(7):932-4. PubMed ID: 2974702
    [Abstract] [Full Text] [Related]

  • 6. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H.
    Acta Obstet Gynecol Scand; 1988 Jul; 67(2):171-4. PubMed ID: 2972160
    [Abstract] [Full Text] [Related]

  • 7. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
    Weijers MJ.
    Clin Ther; 1982 Jul; 4(5):359-66. PubMed ID: 6461412
    [Abstract] [Full Text] [Related]

  • 8. Desogestrel, a new progestational compound, and the liver.
    Weijers MJ.
    Arzneimittelforschung; 1983 Jul; 33(5):774-6. PubMed ID: 6223646
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
    Halbe HW, de Melo NR, Bahamondes L, Petracco A, Lemgruber M, de Andrade RP, da Cunha DC, Guazelli CA, Baracat EC.
    Eur J Contracept Reprod Health Care; 1998 Sep; 3(3):113-20. PubMed ID: 9853201
    [Abstract] [Full Text] [Related]

  • 10. A multicenter efficacy and safety study of an oral contraceptive containing 150 micrograms desogestrel and 30 micrograms ethinyl estradiol.
    Walling M.
    Contraception; 1992 Oct; 46(4):313-26. PubMed ID: 1486770
    [Abstract] [Full Text] [Related]

  • 11. [Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
    Weijers MJ.
    Fortschr Med; 1982 Apr 29; 100(16):764-7. PubMed ID: 6211403
    [Abstract] [Full Text] [Related]

  • 12. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Apr 29; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 13. [Clinical experiences with femovan (Gynera)].
    Brill K, Düsterberg B, Albring M.
    Ther Umsch; 1990 Dec 29; 47(12):958-65. PubMed ID: 2096480
    [Abstract] [Full Text] [Related]

  • 14. Clinical review of a monophasic oral contraceptive containing desogestrel and ethinyl estradiol.
    Stone S.
    Int J Fertil Menopausal Stud; 1993 Dec 29; 38 Suppl 3():117-21. PubMed ID: 8260969
    [Abstract] [Full Text] [Related]

  • 15. A multicenter clinical evaluation of a new monophasic combination: Minulet (gestodene and ethinyl estradiol).
    de Andrade RP.
    Int J Fertil; 1989 Sep 29; 34 Suppl():22-30. PubMed ID: 2576253
    [Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles].
    Bilotta P, Favilli S.
    Minerva Ginecol; 1987 Dec 29; 39(12):855-69. PubMed ID: 3329705
    [No Abstract] [Full Text] [Related]

  • 17. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive.
    Anttila L, Kunz M, Marr J.
    Contraception; 2009 Nov 29; 80(5):445-51. PubMed ID: 19835718
    [Abstract] [Full Text] [Related]

  • 18. Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol.
    Lammers P, op ten Berg M.
    Acta Obstet Gynecol Scand; 1991 Nov 29; 70(6):497-500. PubMed ID: 1837199
    [Abstract] [Full Text] [Related]

  • 19. [Clinical study of a low-dose contraceptive--Femodene].
    Rachev E, Damianov L, Dukovski A, Katsarova M.
    Akush Ginekol (Sofiia); 1995 Nov 29; 34(3):71-3. PubMed ID: 8787249
    [Abstract] [Full Text] [Related]

  • 20. Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
    Rákóczi I, Gerö G, Demeter J, Gáti I.
    Arzneimittelforschung; 1985 Nov 29; 35(3):630-3. PubMed ID: 3158320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.